Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma

<div><i>MRI brain</i>. (a) An axial, postcontrast-enhanced, fat-saturated T1-weighted image of the brain shows a 2.0 x 1.0 cm right parietal mass with ill-defined area of enhancement. (b) An axial, contrast enhanced, fat-saturated T1-weighted image of the brain, 3 weeks after therapy with cabozantinib, shows resolution of the prior mass and surrounding enhancement.</div>

Case Reports in Urology

fig1

Figure 1

Figure 1: Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma 